Riskpilot← Back to searchSign inGet full accessBioEndev Solution AB
ABActiveOrg 5591630180Korsvägen 1Research and experimental development on natural sciences and engineering · NACE 7210Est. 20180 employees
Revenue 2024
SEK 0
EBITDA margin
—
0% vs 2023
Equity ratio
100.0%
Financial strength
Net profit 2024
SEK 12,3M
+20685% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -3K | +0% |
| Net profit | SEK 12,3M | +20685% |
| Total assets | SEK 12,4M | +7713% |
| Equity | SEK 12,4M | +7713% |
| Employees | 0 | — |
Legal name
BioEndev Solution AB
Org number
5591630180
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
20 juni 2018
Share capital
SEK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna
Company purpose
Bolaget har till föremål att tillverka och försälja torrefieringsanläggningar. Bolaget kan även äga aktier i andra bolag om ägaren så beslutar.
Address
Korsvägen 1
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 0 | 80 | 2 186 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — | — | — |
| EBITDA | −790 | −12 369 | −2 574 | −4 | 37 | −3 | −3 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | — | — |
| EBIT | −790 | −12 369 | −2 574 | −4 | 37 | −3 | −3 |
| Net financials | — | — | — | — | 33 | 62 | — |
| Profit before tax | −790 | −12 369 | −2 574 | 2 546 | 70 | 59 | 12 263 |
| Tax | −0 | −0 | −0 | −0 | −0 | — | — |
| Net profit | −790 | −12 369 | −2 574 | 2 546 | 70 | 59 | 12 263 |
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Total assets | 1 875 | 2 868 | 428 | 2 803 | 2 833 | 159 | 12 422 |
| Equity | 1 310 | 1 141 | 217 | 2 763 | 2 833 | 159 | 12 422 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | — | — |
| Short-term debt | 565 | 1 726 | 210 | 40 | 0 | — | 0 |
| Total debt | 565 | 1 726 | 210 | 40 | — | — | — |
EBITDA margin
-300000.0%
This company
15.8%
Market median
-1898834% vs market
20182024
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
20182024
Return on equity
98.7%
This company
18.4%
Market median
+436% vs market
20182024
Net profit margin
1226300000.0%
This company
8.1%
Market median
+15139506073% vs market
20182024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20182024
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20182024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-06-01 – 2018-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
AJ Chief Auditor | Chief Auditor | 2020 | — | — |
KM Chief Auditor | Chief Auditor | 2020 | — | — |
JE Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Chairman | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2020 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
BioEndev AB | Company | 100.0% | 100.0% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Umeå Kommunföretag Aktiebolag
BioEndev Solution AB Board members of BioEndev Solution AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anders Jakob Rinzén | Chief Auditor | 0 companies |
| Kent Mikael Joakim Åström | Chief Auditor | 0 companies |
| Johan Erik Berggren | Chief Executive Officer | 0 companies |
| Johan Fredrik Lundberg | Board of Directors | 0 companies |
| Takeshi Otsu | Board of Directors | 0 companies |
| Bengt Mårten Henriksson | Chairman | 0 companies |
| Mitsuru Bessho | Board of Directors | 0 companies |
| Bo Anders Nordin | Board of Directors | 0 companies |
| Karin Birgitta Hedlund | Board of Directors | 0 companies |